• GARD®skin
    OECD TG 442E

    THE FIRST AND ONLY Genomics and Machine-learning based in vitro skin sensitization assay

    Get a quote

  • Do you have “difficult-to-test” samples?

    UVCBs, Natural Extracts, Metals, and more

    Read more

Sensitization Testing with GARD®

Regulatory Toxicity Testing

Biological Evaluation of Medical Devices

GARD®: advancing NAMs for sensitization testing

Stay informed with SenzaGen’s latest scientific development!
Sign up to receive updates

SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.

GLP Compliant Laboratory

READ MORE

Meet Us.

ASCCT 13th Annual Meeting

October 28 - October 30
EVENT CALENDAR

Press Releases

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
18 Dec, 2023
News
IR
English
Corporate Information
Sales
Order
SenzaGen secures SEK 1.7m order from a new global biotech industry leader
29 Nov, 2023
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Other
SenzaGen changes its market maker to Carnegie
08 Nov, 2023
News
IR
English
Corporate Information
Other Corporate Information
SenzaGen ranked one of Sweden's fastest-growing technology companies
Next

News Posts

Subscribe


Prenumerera